Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camilo E Fadul

Showing results (41-50 of 91) with videos related to

Pageof 10
Sort By:
Nature Communications|November 26, 2016
5-Hydroxymethylcytosine localizes to enhancer elements and is associated with survival in glioblastoma patientsKevin C Johnson, E Andres Houseman, Jessica E King, et al.
Journal of Neuro-Oncology|April 18, 2014
A phase 2 trial of verubulin for recurrent glioblastoma: a prospective study by the Brain Tumor Investigational Consortium (BTIC)Marc C Chamberlain, Sean Grimm, Surasak Phuphanich, et al.
Clinics (Sao Paulo, Brazil)|May 16, 2012
Temozolomide in aggressive pituitary adenomas and carcinomasLeon D Ortiz, Luis V Syro, Bernd W Scheithauer, et al.
Journal of Neuro-Oncology|December 13, 2012
A phase II trial of oral gimatecan for recurrent glioblastomaJethro Hu, Patrick Y Wen, Lauren E Abrey, et al.
Seizure|June 26, 2012
Seizure prognosis of patients with low-grade tumorsCynthia A Kahlenberg, Camilo E Fadul, David W Roberts, et al.
BMJ Case Reports|July 14, 2025
Radiation-induced cerebral cavernous malformation following stereotactic radiosurgery for a brain metastasisBardia Hajikarimloo, Salem M Tos, Georgios Mantziaris, et al.
Cancer Letters|June 9, 2009
Ex vivo expansion of tumor specific lymphocytes with IL-15 and IL-21 for adoptive immunotherapy in melanomaEduardo Huarte, Jan Fisher, Mary Jo Turk, et al.
Pituitary|September 16, 2011
Anti-VEGF therapy in pituitary carcinomaLeon D Ortiz, Luis V Syro, Bernd W Scheithauer, et al.
The Lancet. Oncology|August 30, 2024
Defining the quality of interdisciplinary care for patients with brain metastases: modified Delphi panel recommendationsCamilo E Fadul, Jason P Sheehan, Julio Silvestre, et al.
Clinical Colorectal Cancer|September 10, 2009
Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokinesJohn P Mongan, Camilo E Fadul, Bernard F Cole, et al.
Pageof 10

Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
Nature Communications|November 26, 2016
5-Hydroxymethylcytosine localizes to enhancer elements and is associated with survival in glioblastoma patientsKevin C Johnson, E Andres Houseman, Jessica E King, et al.
Journal of Neuro-Oncology|April 18, 2014
A phase 2 trial of verubulin for recurrent glioblastoma: a prospective study by the Brain Tumor Investigational Consortium (BTIC)Marc C Chamberlain, Sean Grimm, Surasak Phuphanich, et al.
Clinics (Sao Paulo, Brazil)|May 16, 2012
Temozolomide in aggressive pituitary adenomas and carcinomasLeon D Ortiz, Luis V Syro, Bernd W Scheithauer, et al.
Journal of Neuro-Oncology|December 13, 2012
A phase II trial of oral gimatecan for recurrent glioblastomaJethro Hu, Patrick Y Wen, Lauren E Abrey, et al.
Seizure|June 26, 2012
Seizure prognosis of patients with low-grade tumorsCynthia A Kahlenberg, Camilo E Fadul, David W Roberts, et al.
BMJ Case Reports|July 14, 2025
Radiation-induced cerebral cavernous malformation following stereotactic radiosurgery for a brain metastasisBardia Hajikarimloo, Salem M Tos, Georgios Mantziaris, et al.
Cancer Letters|June 9, 2009
Ex vivo expansion of tumor specific lymphocytes with IL-15 and IL-21 for adoptive immunotherapy in melanomaEduardo Huarte, Jan Fisher, Mary Jo Turk, et al.
Pituitary|September 16, 2011
Anti-VEGF therapy in pituitary carcinomaLeon D Ortiz, Luis V Syro, Bernd W Scheithauer, et al.
The Lancet. Oncology|August 30, 2024
Defining the quality of interdisciplinary care for patients with brain metastases: modified Delphi panel recommendationsCamilo E Fadul, Jason P Sheehan, Julio Silvestre, et al.
Clinical Colorectal Cancer|September 10, 2009
Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokinesJohn P Mongan, Camilo E Fadul, Bernard F Cole, et al.
Pageof 10